Stock Award Programs | The Company’s stock incentive plan is administered by the Compensation Committee and authorizes the grant or award of incentive stock options, non-qualified stock options (NQSO), restricted stock awards (RSA), stock appreciation rights, dividend equivalent rights, performance unit awards and phantom shares. The Company issues new shares of common stock upon the exercise of stock options. Any shares associated with options forfeited are added back to the number of shares that underlie stock options to be granted under the stock incentive plan. The Company has issued restricted stock awards and non-qualified stock option awards as described below. Valuation of Stock Awards Restricted Stock. Non-Qualified Stock Options. Restricted Stock Award Activity A summary of RSA activity as of March 31, 2019 and 2018, and changes during the three month periods ended March 31, 2019 and 2018 are set forth below: 2019 2018 NON-VESTED AWARDS (Unaudited) Non-vested awards outstanding, January 1, 300,000 - Granted (+) - 980,851 (2 ) Vested (-) 99,990 (1 ) - Non-vested awards outstanding, March 31, 200,010 (3 ) 980,851 (3 ) Weighted-average remaining contractual life (in years) 1.76 1.3 Unamortized RSA compensation expense $ 119,573 $ 474,116 Aggregate intrinsic value of RSAs non-vested, March 31 $ 84,004 $ 568,894 Aggregate intrinsic value of RSAs vested, March 31 $ - $ - (1) During the three month period ended March 31, 2019, 99,990 RSAs vested during the period. (2) During the three month period ended March 31, 2018, the Company granted 980,851 RSAs, of which i) 300,000 of RSAs were awarded as part of additional compensation plan to align key employees with the Company’s long term financial goals, and ii) 680,851 were awarded to members of the Company’s board of directors as part of their annual board retainer fee and vested during the period. (3) There were no RSAs that were cancelled or expired during the three month periods ended March 31, 2019 and 2018, respectively. Non-Qualified Stock Option Award Activity A summary of stock option activity as of March 31, 2019 and 2018, and changes during the three month periods ended March 31, 2019 and 2018 are set forth below: 2019 2018 Weighted Weighted Average Average Grant Date Grant Date Shares Fair Value Shares Fair Value NON-VESTED AWARDS (Unaudited) Non-vested balances, January 1, 2,067,503 $ 0.36 2,685,004 $ 0.35 Granted (+) 25,000 (1) $ 0.15 -(1) $ 0.00 Non-vested balances, March 31, 2,092,503 $ 0.35 2,685,004 $ 0.35 2019 2018 Weighted Weighted Average Average Shares Exercise Price Shares Exercise Price OUTSTANDING AND EXERCISABLE AWARDS (Unaudited) Awards outstanding, January 1, 4,013,334 $ 0.58 4,173,334 $ 0.60 Granted (+) 25,000 (1) $ 0.41 - (1) $ 0.00 Exercised (-) - $ 0.00 50,000 (2) $ 0.44 Awards outstanding, March 31, 4,038,334 $ 0.58 4,123,334 $ 0.00 Awards vested and expected to vest, March 31, 3,447,184 $ 0.58 3,527,089 $ 0.60 Awards outstanding and exercisable, March 31, 1,945,831 $ 0.56 1,438,330 $ 0.62 (1) During the three month period ended March 31, 2019, there were NQSO grants of 25,000 granted to a non-employee as compensation for investor relations services. This stock award grant was valued using a Black-Scholes model that assumed a 1-year vesting period, 2-year option term, a risk free rate of 2.5%, volatility of 64.6%, no assumed dividend yield, and a forfeiture rate estimate of 1.2%. During the three month period ended March 31, 2018, there were no grants of non-qualified stock options. (2) The total intrinsic value of stock options exercised during the three month ended March 31, 2018 was approximately $5,500. The weighted-average remaining contractual life of the non-qualified stock options outstanding, exercisable, and vested and expected to vest as of March 31, 2019 were 2.9 years, 2.7 years and 2.7 years, respectively. The aggregate intrinsic value associated with options outstanding, vested and expected to vest, and exercisable as of March 31, 2019 was approximately $7,250, $6,209 and $3,625, respectively. Aggregate intrinsic value represents total pretax intrinsic value (the difference between WidePoint’s closing stock price on March 31, 2019 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on March 31, 2019. The intrinsic value will change based on the fair market value of WidePoint’s stock. Share-Based Compensation Expense Share-based compensation (including restricted stock awards) represents both stock options based expense and stock grant expense. The following table sets forth the composition of stock compensation expense included in general and administrative expense for the periods then ended: THREE MONTHS ENDED MARCH 31, 2019 2018 (Unaudited) Restricted stock compensation expense $ 16,737 $ 49,884 Non-qualified option stock compensation expense 72,529 74,520 Total share-based compensation before taxes $ 89,266 $ 124,404 At March 31, 2019, the Company had approximately $394,600 of total unamortized share-based compensation expense, net of estimated forfeitures, related to stock option plans that will be recognized over the weighted average remaining period of 1.1 years. |